Skip Nav Destination
Radioimmunotherapy of non-Hodgkin lymphomas
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity
Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia
Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia
Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation
Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell
Issue Archive
January 15 2003
In this Issue
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
ERRATA
REVIEW ARTICLES
Radioimmunotherapy of non-Hodgkin lymphomas
Clinical Trials & Observations
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity
Clinical Trials & Observations
Michael Boeckh,Wendy Leisenring,Stanley R. Riddell,Raleigh A. Bowden,Meei-Li Huang,David Myerson,Terry Stevens-Ayers,Mary E. D. Flowers,Terri Cunningham,Lawrence Corey
Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease
Clinical Trials & Observations
Jessica N. Henderson,Michael J. Noetzel,Robert C. McKinstry,Desiree A. White,Melissa Armstrong,Michael R. DeBaun
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
Clinical Trials & Observations
Ute Rehwald,Holger Schulz,Marcel Reiser,Markus Sieber,Jan Oliver Staak,Franck Morschhauser,Christoph Driessen,Thomas Rüdiger,Konrad Müller-Hermelink,Volker Diehl,Andreas Engert,on behalf of the German Hodgkin Lymphoma Study Group (GHSG)
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia
Clinical Trials & Observations
Guido Marcucci,John C. Byrd,Guowei Dai,Marko I. Klisovic,Peter J. Kourlas,Donn C. Young,Spero R. Cataland,Diane B. Fisher,David Lucas,Kenneth K. Chan,Pierluigi Porcu,Zhong-Pin Lin,Sherif F. Farag,Stanley R. Frankel,James A. Zwiebel,Eric H. Kraut,Stanley P. Balcerzak,Clara D. Bloomfield,Michael R. Grever,Michael A. Caligiuri
Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia
Clinical Trials & Observations
Ahmet H. Elmaagacli,Rudolf Peceny,Nina Steckel,Rudolf Trenschel,Hellmut Ottinger,Hans Grosse-Wilde,Ulrich W. Schaefer,Dietrich W. Beelen
Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients
Clinical Trials & Observations
Brief Report
Dana G. Wolf,Nell S. Lurain,Tsila Zuckerman,Ron Hoffman,Judith Satinger,Alik Honigman,Niveen Saleh,Emanuel S. Robert,Jacob M. Rowe,Zipora Kra-Oz
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation
Clinical Trials & Observations
Brief Report
Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia
Clinical Trials & Observations
Brief Report
Hagop M. Kantarjian,Moshe Talpaz,Susan O'Brien,Francis Giles,Guillermo Garcia-Manero,Stefan Faderl,Deborah Thomas,Jianqin Shan,Mary Beth Rios,Jorge Cortes
GENE THERAPY
HEMATOPOIESIS
Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-β and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells
Zhouhong Cao,Kathleen C. Flanders,Daniel Bertolette,Lyudmila A. Lyakh,Jens U. Wurthner,W. Tony Parks,John J. Letterio,Francis W. Ruscetti,Anita B. Roberts
Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia
Sarah M. Jacobs-Helber,Kwan-ho Roh,Daniel Bailey,Emmanuel N. Dessypris,John J. Ryan,Jingchun Chen,Amittha Wickrema,Dwayne L. Barber,Paul Dent,Stephen T. Sawyer
Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)–transfected human stromal cells
Yutaka Kawano,Masayoshi Kobune,Miki Yamaguchi,Kiminori Nakamura,Yoshinori Ito,Katsunori Sasaki,Sho Takahashi,Takafumi Nakamura,Hiroki Chiba,Tsutomu Sato,Takuya Matsunaga,Hiroshi Azuma,Kenji Ikebuchi,Hisami Ikeda,Junji Kato,Yoshiro Niitsu,Hirofumi Hamada
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production
Adrian E. Morelli,Adriana T. Larregina,William J. Shufesky,Alan F. Zahorchak,Alison J. Logar,Glenn D. Papworth,Zhiliang Wang,Simon C. Watkins,Louis D. Falo, Jr,Angus W. Thomson
NEOPLASIA
The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate
Christine Schuster,Karin Forster,Henning Dierks,Annika Elsässer,Gerhard Behre,Nicola Simon,Susanne Danhauser-Riedl,Michael Hallek,Markus Warmuth
Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate–resistant Bcr-Abl kinases
Markus Warmuth,Nicola Simon,Olga Mitina,Ruth Mathes,Doriano Fabbro,Paul W. Manley,Elisabeth Buchdunger,Karin Forster,Ismail Moarefi,Michael Hallek
Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays
Juan F. Garcı́a,Francisca I. Camacho,Manuel Morente,Máximo Fraga,Carlos Montalbán,Tomás Álvaro, Carmen Bellas,Ángel Castaño,Ana Dı́ez,Teresa Flores,Carmen Martı́n,Miguel A. Martı́nez,Francisco Mazorra,Javier Menárguez,Maria J. Mestre,Manuela Mollejo,Ana I. Sáez,Lydia Sánchez,Miguel A. Piris,for the Spanish Hodgkin Lymphoma Study Group
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell
Brief Report
Tiemo Katzenberger,Andreas Lohr,Stephan Schwarz,Martin Dreyling,Julia Schoof,Christina Nickenig,Stephan Stilgenbauer,Jörg Kalla,M. Michaela Ott,Hans Konrad Müller-Hermelink,German Ott
PHAGOCYTES
Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10
Dominique Berrebi,Stefano Bruscoli,Nicolas Cohen,Arnaud Foussat,Graziella Migliorati,Laurence Bouchet-Delbos,Marie-Christine Maillot,Alain Portier,Jacques Couderc,Pierre Galanaud,Michel Peuchmaur,Carlo Riccardi,Dominique Emilie
RED CELLS
TRANSFUSION MEDICINE
TRANSPLANTATION
CORRESPONDENCE
-
Cover Image
Cover Image
![issue cover]()
Advertisement
Email alerts
Advertisement
